YOANDIS MORALES MARTIN: Open Payments
NPI 1841076551 · LOUISVILLE, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$337 in 20 payments from 7 companies in 2025. Trend: 2023 $54 · 2024 $426 · 2025 $337
Food & beverage: $337
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 10 | $143 |
| Vanda Pharmaceuticals Inc. | 4 | $85 |
| Exact Sciences Corporation | 2 | $35 |
| Lilly USA, LLC | 1 | $21 |
| Lundbeck LLC | 1 | $20 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $19 |
| AstraZeneca Pharmaceuticals LP | 1 | $14 |
Products named: VRAYLAR, HETLIOZ, Cologuard Collection Kit, QULIPTA, JARDIANCE, FANAPT, REXULTI, CAPLYTA.
Industry payments across KY — which companies pay providers there.
